Home » INCB

INCB

Item 5. Implementation of the international drug control treaties (Tuesday morning)

Chair: We will consider scheduling recommendations by WHO and INCB.  CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …

Read more

Item 5. Implementation of the international drug control treaties (Monday afternoon)

(c) International Narcotics Control Board Colombia: (TBA) Pakistan:  Pakistan acknowledges and appreciates the effective role and efforts of the INCB in the collection of data, in-depth analysis, and compilation of the comprehensive report. We believe that the INCB report for 2023 will provide assistance to member states in aligning their national priorities and responses to …

Read more

CND Intersessional Meeting

Chair: First and foremost, I would like to welcome you to the first intersessional meeting of a CND during this ssession. To start, I want to ensure that we’re aligned on the significant matters we’ve encountered, particularly regarding the outcome document. First of all though, the floor is the Secretariat’s. Secretariat:  Thank you, Mr. Chair. Good …

Read more

CND Reconvened 66th Session

Chair: Good Morning. The focus of our discussion pertains to Strategic Management budgetary and administrative motions in the context of our economy. Yesterday, in collaboration with the CCP CJ, we deliberated on the Consolidated budget for the biennium 2024-2025 for the United Nations Office on Drugs and Crime, referencing Containers document 5.2 (2013) and 15/2017, …

Read more

CND Thematic Discussion / Session 11 – Low availability of internationally controlled substances for medical & scientific purposes

Chair: Good Morning. Yesterday we had a fruitful discussion on the issues of the consequences and risk associated with non medical use of drugs. Today we will be discussing the low availability of nationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care. Before we start a discussion, …

Read more

CND Thematic Discussions / Session 7 – Increase in drug-related deaths – unmet need for drug treatment and health services

Chair: Good morning, everyone. Welcome to the second part of the 2023 Thematic Discussion of the Commission on Narcotic Drugs on the implementation of all international drug policy commitments following the 2019 ministerial declaration (…) Agenda is adopted. Thank you very much. Secretariat: (organizational announcements) Director of the Division of Policy Analysis and Public Affairs …

Read more